Free Trial

Canopy Growth (TSE:WEED) Trading Up 2.8% - Here's What Happened

Canopy Growth logo with Medical background

Canopy Growth Corp (TSE:WEED - Get Free Report) traded up 2.8% during trading on Thursday . The company traded as high as C$2.62 and last traded at C$2.55. 497,471 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 1,625,473 shares. The stock had previously closed at C$2.48.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on WEED. ATB Capital cut their price objective on shares of Canopy Growth from C$4.00 to C$3.20 and set an "underperform" rating for the company in a report on Monday, February 10th. Canaccord Genuity Group dropped their target price on shares of Canopy Growth from C$2.50 to C$1.50 and set a "sell" rating for the company in a research report on Monday, February 10th. Four research analysts have rated the stock with a sell rating and one has given a hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Reduce" and a consensus price target of C$5.64.

View Our Latest Stock Analysis on Canopy Growth

Canopy Growth Trading Down 5.9%

The company has a quick ratio of 2.32, a current ratio of 1.39 and a debt-to-equity ratio of 120.38. The stock's 50 day moving average is C$1.73 and its 200-day moving average is C$2.93. The company has a market cap of C$384.47 million, a PE ratio of -0.35, a P/E/G ratio of -0.01 and a beta of 1.79.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Featured Articles

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines